PET/MRI Evaluation of Cardiac Amyloid
NCT03119558
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Cardiac Amyloidosis
Interventions
DRUG:
18F-Florbetaben (Neuraceq®) PET/MRI
Sponsor
Stanford University